Urology
Reply to Editorial Comment on "Clinician- and Geographic-level Variation in Utilization of Sacral Neuromodulation and OnabotulinumtoxinA Injections Among Medicare Beneficiaries With Overactive Bladder".
Leo D Dreyfuss, Anne M Suskind
Published: 202510.1016/j.urology.2025.12.017
No abstract available for this study.